Back to News
investment

Milestone Pharmaceuticals Inc. (MIST) Discusses FDA Approval and Clinical Insights for CARDAMYST Nasal Spray in PSVT Treatment - Slideshow

Seeking Alpha
Loading...
1 min read
1 views
0 likes
Milestone Pharmaceuticals Inc. (MIST) Discusses FDA Approval and Clinical Insights for CARDAMYST Nasal Spray in PSVT Treatment - Slideshow

Summarize this article with:

SA Transcripts157.36K FollowersFollow5ShareSaveComment(1)The following slide deck was published by Milestone Pharmaceuticals Inc. in conjunction with this event. This article was written bySA Transcripts157.36K FollowersFollowSeeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Read Original

Source Information

Source: Seeking Alpha